What is Guardant Health's stock-based comp?

Guardant Health (GH) reported stock-based comp of $47.61M in Q1 2026.

How has Guardant Health's stock-based comp changed year-over-year?

Guardant Health's stock-based comp increased by 26.1% year-over-year, from $37.76M to $47.61M.

What is the long-term trend for Guardant Health's stock-based comp?

Over 4 years (2021 to 2025), Guardant Health's stock-based comp has grown at a 2.4% compound annual growth rate (CAGR), from $151.45M to $166.22M.

What does stock-based comp mean?

Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.

Guardant Health GH Stock-Based Comp

Stock-Based Comp at other companies

Myriad GeneticsMYGN

$6.5M-31.6%

NeoGenomicsNEO

$8.22M-32.7%

IlluminaILMN

$60M-17.8%

VeracyteVCYT

$12.76M+16.5%

Biodesix, Inc.BDSX

$1.12M+14.7%

Adaptive BiotechnologiesADPT

$11.93M-1.8%

Other financials

Income statement

See full

Revenue$301.7M+48.3%

Gross profit$196.7M+52.8%

Operating income-$121.4M-9.3%

Net income-$112.1M-17.8%

EPS (diluted)-$0.85-10.4%

Balance sheet

See full

Cash & equivalents$1.1B+37.0%

Total debt$1.7B+30.5%

Total equity-$181.1M+27.8%

Total assets$1.9B+42.5%

Cash flow

See full

Operating cash flow-$65.6M-4.7%

CapEx$5.6M+25.1%

Free cash flow-$71.2M-6.0%

Valuation

See full

Market cap$19.04B+255%

Enterprise value$19.65B+229%

P/S17.6×+11.2×

Profitability

See full

Gross margin64.9%+3.6pp

Operating margin-41.4%-9.4pp

Net margin-40.1%-8.1pp

FCF margin-22%-6.7pp

Returns & leverage

See full

Return on equity-438.1%-1,655pp

Debt / equity3×—

Current ratio4.7×+0.6×

Where this comes from

Reported directly by Guardant Health in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Guardant Health’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Guardant Health's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Guardant Health's stock-based comp?: Guardant Health (GH) reported stock-based comp of $47.61M in Q1 2026.
How has Guardant Health's stock-based comp changed year-over-year?: Guardant Health's stock-based comp increased by 26.1% year-over-year, from $37.76M to $47.61M.
What is the long-term trend for Guardant Health's stock-based comp?: Over 4 years (2021 to 2025), Guardant Health's stock-based comp has grown at a 2.4% compound annual growth rate (CAGR), from $151.45M to $166.22M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.